Annual EBITDA
-$13.79 M
-$2.83 M-25.80%
October 1, 2024
Summary
- As of February 25, 2025, ANIX annual EBITDA is -$13.79 million, with the most recent change of -$2.83 million (-25.80%) on October 1, 2024.
- During the last 3 years, ANIX annual EBITDA has fallen by -$718.00 thousand (-5.49%).
- ANIX annual EBITDA is now -2240.74% below its all-time high of -$589.30 thousand, reached on October 31, 2015.
Performance
ANIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.15 M
+$435.00 K+12.12%
October 1, 2024
Summary
- As of February 25, 2025, ANIX quarterly EBITDA is -$3.15 million, with the most recent change of +$435.00 thousand (+12.12%) on October 1, 2024.
- Over the past year, ANIX quarterly EBITDA has stayed the same.
- ANIX quarterly EBITDA is now -179.97% below its all-time high of $3.94 million, reached on January 31, 2015.
Performance
ANIX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$13.79 M
-$115.00 K-0.84%
October 1, 2024
Summary
- As of February 25, 2025, ANIX TTM EBITDA is -$13.79 million, with the most recent change of -$115.00 thousand (-0.84%) on October 1, 2024.
- Over the past year, ANIX TTM EBITDA has stayed the same.
- ANIX TTM EBITDA is now -4698.00% below its all-time high of $300.00 thousand, reached on July 1, 1984.
Performance
ANIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANIX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.8% | 0.0% | 0.0% |
| 3 y3 years | -5.5% | 0.0% | 0.0% |
| 5 y5 years | -25.3% | 0.0% | 0.0% |
ANIX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.8% | +0.3% | -23.9% | +18.5% | -25.8% | +13.2% |
| 5 y | 5-year | -39.5% | +0.3% | -42.1% | +27.9% | -48.6% | +13.2% |
| alltime | all time | -2240.7% | +0.3% | -180.0% | +42.9% | -4698.0% | +18.9% |
Anixa Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | -$13.79 M(+25.8%) | -$3.15 M(-12.1%) | -$13.79 M(+0.8%) |
| Jul 2024 | - | -$3.59 M(+3.9%) | -$13.68 M(+5.9%) |
| Apr 2024 | - | -$3.46 M(-3.9%) | -$12.92 M(+7.5%) |
| Jan 2024 | - | -$3.60 M(+18.3%) | -$12.02 M(+9.6%) |
| Oct 2023 | -$10.96 M(-20.7%) | -$3.04 M(+7.3%) | -$10.96 M(-4.9%) |
| Jul 2023 | - | -$2.83 M(+11.2%) | -$11.52 M(+0.4%) |
| Apr 2023 | - | -$2.55 M(+0.1%) | -$11.48 M(-8.2%) |
| Jan 2023 | - | -$2.54 M(-29.3%) | -$12.51 M(-9.6%) |
| Oct 2022 | -$13.83 M(+5.8%) | -$3.60 M(+29.1%) | -$13.83 M(-3.2%) |
| Jul 2022 | - | -$2.79 M(-22.1%) | -$14.30 M(-10.0%) |
| Apr 2022 | - | -$3.58 M(-7.5%) | -$15.88 M(+7.9%) |
| Jan 2022 | - | -$3.87 M(-4.7%) | -$14.73 M(+12.6%) |
| Oct 2021 | -$13.08 M(+32.2%) | -$4.06 M(-7.1%) | -$13.07 M(+16.3%) |
| Jul 2021 | - | -$4.37 M(+80.6%) | -$11.24 M(+21.1%) |
| Apr 2021 | - | -$2.42 M(+9.1%) | -$9.28 M(-2.3%) |
| Jan 2021 | - | -$2.22 M(-0.4%) | -$9.50 M(-3.9%) |
| Oct 2020 | -$9.89 M(-10.1%) | -$2.23 M(-7.7%) | -$9.89 M(+1.2%) |
| Jul 2020 | - | -$2.41 M(-8.7%) | -$9.77 M(+3.0%) |
| Apr 2020 | - | -$2.64 M(+1.6%) | -$9.49 M(+2.0%) |
| Jan 2020 | - | -$2.60 M(+23.1%) | -$9.30 M(-15.5%) |
| Oct 2019 | -$11.00 M(-17.6%) | -$2.11 M(-0.6%) | -$11.01 M(-19.2%) |
| Jul 2019 | - | -$2.13 M(-13.4%) | -$13.63 M(-19.9%) |
| Apr 2019 | - | -$2.46 M(-43.0%) | -$17.02 M(+7.2%) |
| Jan 2019 | - | -$4.31 M(-9.1%) | -$15.88 M(+18.8%) |
| Oct 2018 | -$13.36 M(+222.8%) | -$4.74 M(-14.2%) | -$13.36 M(+30.2%) |
| Jul 2018 | - | -$5.52 M(+319.2%) | -$10.26 M(+61.0%) |
| Apr 2018 | - | -$1.32 M(-26.4%) | -$6.37 M(+37.7%) |
| Jan 2018 | - | -$1.79 M(+9.4%) | -$4.63 M(+11.8%) |
| Oct 2017 | -$4.14 M(+0.1%) | -$1.64 M(+0.3%) | -$4.14 M(+24.5%) |
| Jul 2017 | - | -$1.63 M(-480.7%) | -$3.33 M(+29.2%) |
| Apr 2017 | - | $428.30 K(-132.9%) | -$2.57 M(-36.5%) |
| Jan 2017 | - | -$1.30 M(+58.6%) | -$4.06 M(-2.0%) |
| Oct 2016 | -$4.14 M(+602.2%) | -$821.20 K(-6.6%) | -$4.14 M(-5.9%) |
| Jul 2016 | - | -$879.10 K(-16.6%) | -$4.40 M(-10.7%) |
| Apr 2016 | - | -$1.05 M(-23.9%) | -$4.92 M(-16.8%) |
| Jan 2016 | - | -$1.38 M(+28.1%) | -$5.92 M(+905.6%) |
| Oct 2015 | -$589.30 K(-92.7%) | -$1.08 M(-23.1%) | -$588.30 K(-75.5%) |
| Jul 2015 | - | -$1.40 M(-31.4%) | -$2.40 M(+989.1%) |
| Apr 2015 | - | -$2.05 M(-151.9%) | -$220.20 K(-76.0%) |
| Jan 2015 | - | $3.94 M(-236.4%) | -$919.10 K(-88.6%) |
| Oct 2014 | -$8.03 M(-10.5%) | -$2.89 M(-473.8%) | -$8.03 M(+1.1%) |
| Jul 2014 | - | $773.20 K(-128.2%) | -$7.94 M(-28.9%) |
| Apr 2014 | - | -$2.75 M(-13.3%) | -$11.17 M(+11.0%) |
| Jan 2014 | - | -$3.17 M(+13.1%) | -$10.06 M(+12.2%) |
| Oct 2013 | -$8.97 M(+111.3%) | -$2.80 M(+14.0%) | -$8.97 M(+11.8%) |
| Jul 2013 | - | -$2.46 M(+49.7%) | -$8.02 M(+29.5%) |
| Apr 2013 | - | -$1.64 M(-20.8%) | -$6.20 M(+14.1%) |
| Jan 2013 | - | -$2.07 M(+11.9%) | -$5.43 M(+28.0%) |
| Oct 2012 | -$4.25 M(-37.3%) | -$1.85 M(+194.5%) | -$4.24 M(-17.5%) |
| Jul 2012 | - | -$629.10 K(-28.3%) | -$5.14 M(-10.1%) |
| Apr 2012 | - | -$877.10 K(-0.8%) | -$5.72 M(-6.7%) |
| Jan 2012 | - | -$884.00 K(-67.9%) | -$6.13 M(-9.5%) |
| Oct 2011 | -$6.77 M(+29.2%) | -$2.75 M(+128.5%) | -$6.77 M(+31.7%) |
| Jul 2011 | - | -$1.21 M(-6.2%) | -$5.14 M(-1.2%) |
| Apr 2011 | - | -$1.29 M(-15.7%) | -$5.20 M(-1.0%) |
| Jan 2011 | - | -$1.52 M(+35.5%) | -$5.26 M(+0.3%) |
| Oct 2010 | -$5.24 M(-28.3%) | -$1.12 M(-11.3%) | -$5.24 M(-30.0%) |
| Jul 2010 | - | -$1.27 M(-5.2%) | -$7.48 M(-7.1%) |
| Apr 2010 | - | -$1.34 M(-11.3%) | -$8.05 M(-0.5%) |
| Jan 2010 | - | -$1.51 M(-55.2%) | -$8.09 M(+1.6%) |
| Oct 2009 | -$7.31 M(+22.3%) | -$3.37 M(+83.3%) | -$7.96 M(+54.1%) |
| Jul 2009 | - | -$1.84 M(+33.5%) | -$5.17 M(+27.0%) |
| Apr 2009 | - | -$1.38 M(-0.3%) | -$4.07 M(-12.9%) |
| Jan 2009 | - | -$1.38 M(+140.0%) | -$4.67 M(-21.9%) |
| Oct 2008 | -$5.98 M(+15.2%) | -$574.60 K(-22.2%) | -$5.98 M(-5.3%) |
| Jul 2008 | - | -$738.60 K(-62.6%) | -$6.31 M(-4.9%) |
| Apr 2008 | - | -$1.98 M(-26.6%) | -$6.64 M(+8.8%) |
| Jan 2008 | - | -$2.69 M(+195.5%) | -$6.10 M(+17.5%) |
| Oct 2007 | -$5.19 M(-31.8%) | -$910.40 K(-14.2%) | -$5.19 M(-14.7%) |
| Jul 2007 | - | -$1.06 M(-26.2%) | -$6.08 M(-15.2%) |
| Apr 2007 | - | -$1.44 M(-19.2%) | -$7.17 M(-12.0%) |
| Jan 2007 | - | -$1.78 M(-1.3%) | -$8.15 M(+7.1%) |
| Oct 2006 | -$7.61 M(+71.0%) | -$1.80 M(-16.1%) | -$7.61 M(+9.5%) |
| Jul 2006 | - | -$2.15 M(-10.9%) | -$6.95 M(+17.4%) |
| Apr 2006 | - | -$2.42 M(+94.5%) | -$5.92 M(+26.3%) |
| Jan 2006 | - | -$1.24 M(+8.4%) | -$4.69 M(+5.3%) |
| Oct 2005 | -$4.45 M(+32.9%) | -$1.15 M(+2.4%) | -$4.45 M(+7.9%) |
| Jul 2005 | - | -$1.12 M(-5.2%) | -$4.13 M(+2.2%) |
| Apr 2005 | - | -$1.18 M(+17.5%) | -$4.04 M(+13.8%) |
| Jan 2005 | - | -$1.00 M(+22.5%) | -$3.55 M(+6.0%) |
| Oct 2004 | -$3.35 M | -$820.20 K(-20.5%) | -$3.35 M(+4.3%) |
| Jul 2004 | - | -$1.03 M(+49.3%) | -$3.21 M(+13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2004 | - | -$691.40 K(-14.0%) | -$2.82 M(-8.7%) |
| Jan 2004 | - | -$804.10 K(+17.6%) | -$3.09 M(+0.3%) |
| Oct 2003 | -$3.09 M(-4.2%) | -$683.70 K(+6.2%) | -$3.09 M(-52.0%) |
| Jul 2003 | - | -$644.00 K(-33.1%) | -$6.42 M(+7.6%) |
| Apr 2003 | - | -$962.10 K(+20.9%) | -$5.97 M(+45.7%) |
| Jan 2003 | - | -$796.10 K(-80.2%) | -$4.10 M(+27.2%) |
| Oct 2002 | -$3.22 M(-6.3%) | -$4.02 M(+1991.7%) | -$3.22 M(-3676.4%) |
| Jul 2002 | - | -$192.30 K(-121.1%) | $90.10 K(-114.3%) |
| Apr 2002 | - | $912.70 K(+1046.6%) | -$627.90 K(-72.5%) |
| Jan 2002 | - | $79.60 K(-111.2%) | -$2.28 M(-33.7%) |
| Oct 2001 | -$3.44 M(-28.7%) | -$709.90 K(-22.0%) | -$3.44 M(-17.8%) |
| Jul 2001 | - | -$910.30 K(+23.0%) | -$4.18 M(-0.5%) |
| Apr 2001 | - | -$740.30 K(-31.3%) | -$4.21 M(-9.7%) |
| Jan 2001 | - | -$1.08 M(-26.0%) | -$4.66 M(-5.0%) |
| Oct 2000 | -$4.82 M(-38.9%) | -$1.46 M(+56.3%) | -$4.90 M(-25.1%) |
| Jul 2000 | - | -$931.50 K(-21.9%) | -$6.55 M(-11.7%) |
| Apr 2000 | - | -$1.19 M(-9.8%) | -$7.42 M(-5.2%) |
| Jan 2000 | - | -$1.32 M(-57.3%) | -$7.82 M(+0.3%) |
| Oct 1999 | -$7.90 M(+16.2%) | -$3.10 M(+72.2%) | -$7.80 M(+21.9%) |
| Jul 1999 | - | -$1.80 M(+12.5%) | -$6.40 M(+1.6%) |
| Apr 1999 | - | -$1.60 M(+23.1%) | -$6.30 M(-1.6%) |
| Jan 1999 | - | -$1.30 M(-23.5%) | -$6.40 M(-7.2%) |
| Oct 1998 | -$6.80 M(+13.3%) | -$1.70 M(0.0%) | -$6.90 M(+4.5%) |
| Jul 1998 | - | -$1.70 M(0.0%) | -$6.60 M(+4.8%) |
| Apr 1998 | - | -$1.70 M(-5.6%) | -$6.30 M(0.0%) |
| Jan 1998 | - | -$1.80 M(+28.6%) | -$6.30 M(+6.8%) |
| Oct 1997 | -$6.00 M(+1.7%) | -$1.40 M(0.0%) | -$5.90 M(-10.6%) |
| Jul 1997 | - | -$1.40 M(-17.6%) | -$6.60 M(-2.9%) |
| Apr 1997 | - | -$1.70 M(+21.4%) | -$6.80 M(+11.5%) |
| Jan 1997 | - | -$1.40 M(-33.3%) | -$6.10 M(+7.0%) |
| Oct 1996 | -$5.90 M(+84.4%) | -$2.10 M(+31.3%) | -$5.70 M(+21.3%) |
| Jul 1996 | - | -$1.60 M(+60.0%) | -$4.70 M(+20.5%) |
| Apr 1996 | - | -$1.00 M(0.0%) | -$3.90 M(+8.3%) |
| Jan 1996 | - | -$1.00 M(-9.1%) | -$3.60 M(+12.5%) |
| Oct 1995 | -$3.20 M(-8.6%) | -$1.10 M(+37.5%) | -$3.20 M(+10.3%) |
| Jul 1995 | - | -$800.00 K(+14.3%) | -$2.90 M(0.0%) |
| Apr 1995 | - | -$700.00 K(+16.7%) | -$2.90 M(-3.3%) |
| Jan 1995 | - | -$600.00 K(-25.0%) | -$3.00 M(-14.3%) |
| Oct 1994 | -$3.50 M(+25.0%) | -$800.00 K(0.0%) | -$3.50 M(0.0%) |
| Jul 1994 | - | -$800.00 K(0.0%) | -$3.50 M(+9.4%) |
| Apr 1994 | - | -$800.00 K(-27.3%) | -$3.20 M(+3.2%) |
| Jan 1994 | - | -$1.10 M(+37.5%) | -$3.10 M(+24.0%) |
| Oct 1993 | -$2.80 M(+47.4%) | -$800.00 K(+60.0%) | -$2.50 M(+13.6%) |
| Jul 1993 | - | -$500.00 K(-28.6%) | -$2.20 M(+4.8%) |
| Apr 1993 | - | -$700.00 K(+40.0%) | -$2.10 M(+16.7%) |
| Jan 1993 | - | -$500.00 K(0.0%) | -$1.80 M(+12.5%) |
| Oct 1992 | -$1.90 M(+35.7%) | -$500.00 K(+25.0%) | -$1.60 M(+6.7%) |
| Jul 1992 | - | -$400.00 K(0.0%) | -$1.50 M(+15.4%) |
| Apr 1992 | - | -$400.00 K(+33.3%) | -$1.30 M(+8.3%) |
| Jan 1992 | - | -$300.00 K(-25.0%) | -$1.20 M(0.0%) |
| Oct 1991 | -$1.40 M(+7.7%) | -$400.00 K(+100.0%) | -$1.20 M(0.0%) |
| Jul 1991 | - | -$200.00 K(-33.3%) | -$1.20 M(0.0%) |
| Apr 1991 | - | -$300.00 K(0.0%) | -$1.20 M(0.0%) |
| Jan 1991 | - | -$300.00 K(-25.0%) | -$1.20 M(0.0%) |
| Oct 1990 | -$1.30 M(+18.2%) | -$400.00 K(+100.0%) | -$1.20 M(-42.9%) |
| Jul 1990 | - | -$200.00 K(-33.3%) | -$2.10 M(+16.7%) |
| Apr 1990 | - | -$300.00 K(0.0%) | -$1.80 M(+28.6%) |
| Jan 1990 | - | -$300.00 K(-76.9%) | -$1.40 M(+40.0%) |
| Oct 1989 | -$1.10 M(-8.3%) | -$1.30 M(-1400.0%) | -$1.00 M(-9.1%) |
| Jul 1989 | - | $100.00 K(0.0%) | -$1.10 M(0.0%) |
| Apr 1989 | - | $100.00 K(0.0%) | -$1.10 M(0.0%) |
| Jan 1989 | - | $100.00 K(-107.1%) | -$1.10 M(0.0%) |
| Oct 1988 | -$1.20 M(0.0%) | -$1.40 M(-1500.0%) | -$1.10 M(0.0%) |
| Jul 1988 | - | $100.00 K(0.0%) | -$1.10 M(0.0%) |
| Apr 1988 | - | $100.00 K(0.0%) | -$1.10 M(0.0%) |
| Jan 1988 | - | $100.00 K(-107.1%) | -$1.10 M(0.0%) |
| Oct 1987 | -$1.20 M(-33.3%) | -$1.40 M(-1500.0%) | -$1.10 M(-31.3%) |
| Jul 1987 | - | $100.00 K(0.0%) | -$1.60 M(0.0%) |
| Apr 1987 | - | $100.00 K(0.0%) | -$1.60 M(0.0%) |
| Jan 1987 | - | $100.00 K(-105.3%) | -$1.60 M(0.0%) |
| Oct 1986 | -$1.80 M(+5.9%) | -$1.90 M(-2000.0%) | -$1.60 M(-5.9%) |
| Jul 1986 | - | $100.00 K(0.0%) | -$1.70 M(0.0%) |
| Apr 1986 | - | $100.00 K(0.0%) | -$1.70 M(0.0%) |
| Jan 1986 | - | $100.00 K(-105.0%) | -$1.70 M(0.0%) |
| Oct 1985 | -$1.70 M(-10.5%) | -$2.00 M(-2100.0%) | -$1.70 M(0.0%) |
| Jul 1985 | - | $100.00 K(0.0%) | -$1.70 M(0.0%) |
| Apr 1985 | - | $100.00 K(0.0%) | -$1.70 M(0.0%) |
| Jan 1985 | - | $100.00 K(-105.0%) | -$1.70 M(0.0%) |
| Oct 1984 | -$1.90 M | -$2.00 M(-2100.0%) | -$1.70 M(-666.7%) |
| Jul 1984 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Apr 1984 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Jan 1984 | - | $100.00 K | $100.00 K |
FAQ
- What is Anixa Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Anixa Biosciences?
- What is Anixa Biosciences annual EBITDA year-on-year change?
- What is Anixa Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Anixa Biosciences?
- What is Anixa Biosciences quarterly EBITDA year-on-year change?
- What is Anixa Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Anixa Biosciences?
- What is Anixa Biosciences TTM EBITDA year-on-year change?
What is Anixa Biosciences annual EBITDA?
The current annual EBITDA of ANIX is -$13.79 M
What is the all time high annual EBITDA for Anixa Biosciences?
Anixa Biosciences all-time high annual EBITDA is -$589.30 K
What is Anixa Biosciences annual EBITDA year-on-year change?
Over the past year, ANIX annual EBITDA has changed by -$2.83 M (-25.80%)
What is Anixa Biosciences quarterly EBITDA?
The current quarterly EBITDA of ANIX is -$3.15 M
What is the all time high quarterly EBITDA for Anixa Biosciences?
Anixa Biosciences all-time high quarterly EBITDA is $3.94 M
What is Anixa Biosciences quarterly EBITDA year-on-year change?
Over the past year, ANIX quarterly EBITDA has changed by $0.00 (0.00%)
What is Anixa Biosciences TTM EBITDA?
The current TTM EBITDA of ANIX is -$13.79 M
What is the all time high TTM EBITDA for Anixa Biosciences?
Anixa Biosciences all-time high TTM EBITDA is $300.00 K
What is Anixa Biosciences TTM EBITDA year-on-year change?
Over the past year, ANIX TTM EBITDA has changed by $0.00 (0.00%)